Literature DB >> 27015287

Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120).

X Papanikolaou1, A Rosenthal2, M Dhodapkar3, J Epstein1, R Khan1, F van Rhee1, Y Jethava1, S Waheed1, M Zangari1, A Hoering2, J Crowley2, D Alapat4, F Davies1, G Morgan1, B Barlogie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27015287      PMCID： PMC4817101          DOI： 10.1038/bcj.2016.19

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  20 in total

1.  Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal.

Authors:  Kelly M McMasters; Celia Chao; Sandra L Wong; Robert C G Martin; Michael J Edwards
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

Review 2.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

3.  Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).

Authors:  Rashid Khan; Madhav Dhodapkar; Adam Rosenthal; Christoph Heuck; Xenofon Papanikolaou; Pingping Qu; Frits van Rhee; Maurizio Zangari; Yogesh Jethava; Joshua Epstein; Shmuel Yaccoby; Antje Hoering; John Crowley; Nathan Petty; Clyde Bailey; Gareth Morgan; Bart Barlogie
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

4.  Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.

Authors:  D Billadeau; B Van Ness; T Kimlinger; R A Kyle; T M Therneau; P R Greipp; T E Witzig
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

5.  Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Authors:  Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.

Authors:  Ernesto Pérez-Persona; María-Belén Vidriales; Gema Mateo; Ramón García-Sanz; Maria-Victoria Mateos; Alfonso García de Coca; Josefina Galende; Guillermo Martín-Nuñez; José M Alonso; Natalia de Las Heras; José M Hernández; Alejandro Martín; Consuelo López-Berges; Alberto Orfao; Jesús F San Miguel
Journal:  Blood       Date:  2007-06-18       Impact factor: 22.113

7.  Cytoplasmic immunoglobulin content in multiple myeloma.

Authors:  B Barlogie; R Alexanian; M Pershouse; L Smallwood; L Smith
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients.

Authors:  D Billadeau; L Quam; W Thomas; N Kay; P Greipp; R Kyle; M M Oken; B Van Ness
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

9.  Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.

Authors:  Angela Dispenzieri; Robert A Kyle; Jerry A Katzmann; Terry M Therneau; Dirk Larson; Joanne Benson; Raynell J Clark; L Joseph Melton; Morie A Gertz; Shaji K Kumar; Rafael Fonseca; Diane F Jelinek; S Vincent Rajkumar
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

10.  Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma.

Authors:  Jan Cerny; Oluwole Fadare; Lloyd Hutchinson; Sa A Wang
Journal:  Eur J Haematol       Date:  2008-05-06       Impact factor: 2.997
View more
  1 in total

Review 1.  MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Authors:  Madhav V Dhodapkar
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.